The Global Clinical Trial Management System Market Size is expected to have lucrative growth due to higher prevalence of diseases, R&D activities in life science and clinical research industries and outsourcing of clinical trial process. Furthermore, raising new product developments, integration of HIS and CTMS and higher adoption of CTMS solutions by end users are some strong factors that may propel the market growth. The global clinical market is expected to reach a value of USD xxx.xx Million by the end of 2025, with a healthy CAGR of x.x% during the forecast period of 2018-2025. However, factors that may hamper growth are dearth of skilled professionals and high cost of CTMS solutions.

the basis type, the global Clinical Trial Management System (CTMS) market is bifurcated into site and enterprise. Enterprise CTMS is at top of the market due to the benefits it offers such as real-time insights into the operational activities like robust reporting, accruals and deviations, tracking and management, enhanced billing compliance of regulatory processes. Additionally, enterprise CTMS helps in bringing consistency in the budget coupled with stronger support for financial management. Bio-Optronics, Forte Research Systems Inc. and Oracle Corporation are the companies which offer enterprise CTMS.

Based on the delivery mode, the web-based CTMS is anticipated to lead the Clinical Trial Management System (CTMS) market share. The growth is attributed to the fact that web-based CTMS solution improves quality of productivity, timeliness and clinical trials, ease of access that enables easier co-relative studies, faster transfer of data and less cost offered than other products.

Based on end-user, the biopharmaceutical and pharmaceutical companies’ classification is anticipated to hold largest clinical trial management system market share. There is higher adoption of CTMS software at time of drug clinical trials by biopharmaceutical and pharmaceutical companies.

the growing prevalence of diseases is favoring the clinical trials in varied regions and increased clinical research outsourcing plays a key role in growth of CTMS market. Higher regulatory requirements in different countries has given rise to higher complexity for clinical trial protocols. Presence of different end users such as clinical research organizations (CRO), healthcare providers and pharmaceuticals has adhered the acceptance of CTMS.

America is considered traditional clinical region. Due to legal and regulatory considerations, clinical trial market has moved from North America to developing countries such as China and India. The U.S. clinical trials have been sponsored and funded by voluntary health organizations and industry, academic groups, and National Institute of Health (NIH).

Central and Eastern Europe offers abundant chance to life science companies for clinical development purpose. With the incremental governmental funding and support for biomedical sciences which made Germany a preferred location for clinical trials.

However, at rank of fastest growing region comes Asia with the enhanced industry patent expiration laws and regulatory laws in different countries which includes India, China and Japan which have expanded clinical trial management system market share in Asia. When compared to Europe and the U.S., Asia has lower cost of conducting clinical trials.

Bio-Optronics, Inc., DSG Inc. (Document Solutions Group), Medidata Solutions, Parexel International Corporation, ERT, Forte Research Systems, Merge Healthcare Incorporated, ArisGlobal, Bioclinica, Inc., Datatrak International, Inc., eClinForce, Inc., Inc., Inc., Mednet Solutions, Inc., Oracle Corporation, and Veeva Systems, Inc. are some of the leading international players operating the global Clinical Trial Management System (CTMS) market.

Key segments of ‘Global Clinical Trial Management System (CTMS) Market’

Based on type, the market has been segmented into,

• Enterprise
• Site

Based on delivery mode, the market has been segmented into,

• Web-based
• Cloud-based
• On premise

Based on region, the market has been segmented into,

• North America
  • U.S.
  • Canada
• Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Belgium
• Netherlands
• Russia

• Latin America

• Brazil
• Mexico
• Argentina

• Asia-Pacific
  • India
  • Japan
  • China
  • Thailand
  • Australia
  • Singapore
  • Malaysia
• The Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa

What to expect from the upcoming report on ‘Global Clinical Trial Management System (CTMS) Market’:

- Future prospects and current trends of the global Clinical Trial Management System (CTMS) market by the end of forecast period (2018-2025)

- Information regarding technological progressions as well as innovations taking place in developing economies

- Supportive initiatives by government likely to influence the market dynamics

- Trends, drivers, opportunities, restraints, challenges and key developments in the market

- In-depth analysis of different market segmentations including regional segmentations, and product types

- Deep analysis about the competitive landscape of the market and the initiatives by them to improve this market

Who should buy this report?

Venture capitalists, Investors, financial institutions, Analysts, Government organizations, regulatory authorities, policymakers ,researchers, strategy managers, and academic institutions looking for insights into the market to determine future strategies.